Skip to main content
ANGIODYNAMICS INC logo

ANGIODYNAMICS INC — Investor Relations & Filings

Ticker · ANGO ISIN · US03475V1017 LEI · 549300W3VKC5ZKMO8C28 US Manufacturing
Filings indexed 1,054 across all filing types
Latest filing 2010-10-20 Director's Dealing
Country US United States of America
Listing US ANGO

About ANGIODYNAMICS INC

https://www.angiodynamics.com/

AngioDynamics Inc. is a medical technology company focused on developing, manufacturing, and selling innovative, minimally invasive devices. The company's core activities center on restoring healthy blood flow in the vascular system and expanding cancer treatment options. Its product portfolio serves healthcare professionals such as interventional radiologists, cardiologists, and surgeons. Key technology platforms include the Auryon System, an advanced peripheral atherectomy device; the AlphaVac System for mechanical thrombectomy; and the NanoKnife System for precise, non-thermal tumor ablation. AngioDynamics is dedicated to improving patient outcomes through technologies designed for vascular access, peripheral vascular disease, and oncology.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2010-10-20 English
PRIMARY DOCUMENT
Director's Dealing
2010-10-20 English
PRIMARY DOCUMENT
Director's Dealing
2010-10-20 English
FORM 10-Q
Interim / Quarterly Report Q1 2011
2010-10-08 English
CURRENT REPORT
Earnings Release Classification · 95% confidence The document is a Form 8-K, which is a current report filed with the SEC to announce major events that shareholders should know about. The text includes an Item 2.02 disclosure about the results of operations and financial condition, referencing a press release dated October 7, 2010, announcing financial results for the fiscal first quarter ended August 30, 2010. It also includes Item 5.02 about a departure of a senior officer. The document does not contain detailed financial statements or comprehensive financial analysis itself but refers to a press release with financial results. The presence of a press release announcing quarterly financial results aligns with an Earnings Release (ER) filing type. The document is not a full quarterly report (IR), nor an annual report (10-K), nor a management discussion (MDA). It is not merely an announcement of a report publication (RPA) because it includes substantive information about the officer departure and financial results announcement. Therefore, the best classification is Earnings Release (ER).
2010-10-07 English
PRIMARY DOCUMENT
Director's Dealing
2010-09-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.